Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof

The present invention relates to bispecific molecules that are capable of localizing an immune effector cell that expresses an activating receptor to a virally infected cell, so as to thereby facilitate the killing of the virally infected cell. In a preferred embodiment, such localization is accompl...

Full description

Saved in:
Bibliographic Details
Main Authors SCOTT KOENIG, BARTON F. HAYNES, LIQIN LIU, CHIA-YING KAO LAM, JEFFREY LEE NORDSTROM, LESLIE S. JOHNSON, Guido FERRARI
Format Patent
LanguageEnglish
Hebrew
Published 29.10.2020
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to bispecific molecules that are capable of localizing an immune effector cell that expresses an activating receptor to a virally infected cell, so as to thereby facilitate the killing of the virally infected cell. In a preferred embodiment, such localization is accomplished using bispecific molecules that are immunoreactive with an activating receptor of an immune effector cell and to an antigen expressed by a cell infected with a virus wherein the antigen is detectably present on the cell infected with the virus at a level that is greater than the level at which the antigen is detected on the virus by the bispecific molecules, and to the use of such bispecific molecules in the treatment of latent viral infections.
Bibliography:Application Number: IL20150241487